These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
930 related articles for article (PubMed ID: 3753994)
21. Superoxide anion production and phospholipase D-mediated generation of diacylglycerol are subnormal after N-formyl-methionyl-leucyl-phenylalanine stimulation of polymorphonuclear granulocytes in polycythemia vera. Samuelsson J; Hansson A; Rosendahl K; Palmblad J J Lab Clin Med; 1993 Feb; 121(2):310-9. PubMed ID: 8381848 [TBL] [Abstract][Full Text] [Related]
22. Chemotactic peptide binding by intact neutrophils from human neonates. Strauss RG; Snyder EL Pediatr Res; 1984 Jan; 18(1):63-6. PubMed ID: 6322097 [TBL] [Abstract][Full Text] [Related]
23. Fc receptor-mediated desensitization of superoxide (O2-) generation response of guinea-pig macrophages and polymorphonuclear leucocytes. Yagawa K; Kaku M; Ichinose Y; Aida Y; Tomoda A Immunology; 1985 Aug; 55(4):629-38. PubMed ID: 2991127 [TBL] [Abstract][Full Text] [Related]
24. Neutrophil chemotactic heterogeneity to N-formyl-methionyl-leucyl-phenylalanine detected by the under-agarose assay. Quitt M; Torres M; McGuire W; Beyer L; Coates TD J Lab Clin Med; 1990 Feb; 115(2):159-64. PubMed ID: 2299263 [TBL] [Abstract][Full Text] [Related]
25. Selective inhibition of human neutrophil chemotaxis to N-formyl-methionyl-leucyl-phenylalanine by sulfones. Harvath L; Yancey KB; Katz SI J Immunol; 1986 Aug; 137(4):1305-11. PubMed ID: 3016092 [TBL] [Abstract][Full Text] [Related]
26. Anti-inflammatory effects of prostaglandin E1: in vivo modulation of the formyl peptide chemotactic receptor on the rat neutrophil. Fantone JC; Marasco WA; Elgas LJ; Ward PA J Immunol; 1983 Apr; 130(4):1495-7. PubMed ID: 6300229 [TBL] [Abstract][Full Text] [Related]
28. Temporal adaptation of neutrophil oxidative responsiveness to n-formyl-methionyl-leucyl-phenylalanine. Acceleration by granulocyte-macrophage colony stimulating factor. English D; Broxmeyer HE; Gabig TG; Akard LP; Williams DE; Hoffman R J Immunol; 1988 Oct; 141(7):2400-6. PubMed ID: 3049807 [TBL] [Abstract][Full Text] [Related]
29. Stimulus- and cumulative dose-dependent inhibition of O2- production by polymorphonuclear leukocytes of patients receiving corticosteroids. Fukushima K; Ando M; Ito K; Suga M; Araki S J Clin Lab Immunol; 1990 Nov; 33(3):117-23. PubMed ID: 1967000 [TBL] [Abstract][Full Text] [Related]
30. Effects of low-density lipoproteins on polymorphonuclear leukocyte functions in vitro. Bonneau C; Couderc R; Roch-Arveiller M; Giroud JP; Raichvarg D J Lipid Mediat Cell Signal; 1994 Sep; 10(3):203-12. PubMed ID: 7812672 [TBL] [Abstract][Full Text] [Related]
31. In vivo and in vitro assessment of porcine neutrophil activation responses to chemoattractants: flow cytometric evidence for the selective absence of formyl peptide receptors. Fletcher MP; Stahl GL; Longhurst JC J Leukoc Biol; 1990 Apr; 47(4):355-65. PubMed ID: 2108228 [TBL] [Abstract][Full Text] [Related]
32. An indirect bioluminescence method for the quantitative measurement of polymorphonuclear cell chemotaxis. Partsch G; Schwarzer C J Biolumin Chemilumin; 1991; 6(3):159-67. PubMed ID: 1660670 [TBL] [Abstract][Full Text] [Related]
33. Chemotactic peptide receptor-cytoskeletal interactions and functional correlations in differentiated HL-60 cells and human polymorphonuclear leukocytes. Rao KM; Currie MS; Cohen HJ; Weinberg JB J Cell Physiol; 1989 Oct; 141(1):119-25. PubMed ID: 2550479 [TBL] [Abstract][Full Text] [Related]
34. Modulation of formyl peptide receptor expression by IL-10 in human monocytes and neutrophils. Thivierge M; Parent JL; Stankova J; Rola-Pleszczynski M J Immunol; 1999 Mar; 162(6):3590-5. PubMed ID: 10092818 [TBL] [Abstract][Full Text] [Related]
35. Functional integrity of cytokineplasts: specific chemotactic and capping responses. Dyett DE; Malawista SE; Van Blaricom G; Melnick DA; Malech HL J Immunol; 1985 Sep; 135(3):2090-4. PubMed ID: 2991379 [TBL] [Abstract][Full Text] [Related]
36. Extracellular cytotoxicity by phagocytosing polymorphonuclear neutrophilic leukocytes: enhancement by a chemotactic stimulus. Dallegri F; Patrone F; Frumento G; Ballestrero A; Sacchetti C Exp Hematol; 1985 Mar; 13(3):209-14. PubMed ID: 2984033 [TBL] [Abstract][Full Text] [Related]
37. Protective effect of indomethacin against chemotactic deactivation of human neutrophils induced by formylated peptide. Perianin A; Gaudry M; Marquetty C; Giroud JP; Hakim J Biochem Pharmacol; 1988 May; 37(9):1693-8. PubMed ID: 2837237 [TBL] [Abstract][Full Text] [Related]
38. Inhibition of human neutrophil chemotaxis by the protein kinase inhibitor, 1-(5-isoquinolinesulfonyl) piperazine. Harvath L; McCall CE; Bass DA; McPhail LC J Immunol; 1987 Nov; 139(9):3055-61. PubMed ID: 2822802 [TBL] [Abstract][Full Text] [Related]